| Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. | |
| | |
MedLine Citation:
|
PMID: 15043516 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The safety and efficacy of selective cyclo-oxygenase-2 inhibitors in inflammatory bowel disease are under investigation. AIM: To assess, in a prospective, open-label trial, the efficacy and safety of rofecoxib (12.5 mg/day) in inflammatory bowel disease patients and controls. METHODS: The inflammatory bowel disease group included 45 inactive patients (25 Crohn's disease; 20 ulcerative colitis) with associated arthralgia. The control group included 30 dyspeptic patients. The efficacy and safety of rofecoxib were assessed in inflammatory bowel disease patients and controls before and after treatment (range, 3 days to 3 months). RESULTS: In inflammatory bowel disease, nine of the 45 patients (20%) required rofecoxib withdrawal due to gastrointestinal symptoms inducing clinical relapse, which subsided on drug discontinuation. The percentage of patients requiring rofecoxib discontinuation was comparable in patients with Crohn's disease and ulcerative colitis (20% vs. 20%), but was higher in inflammatory bowel disease patients than in controls (20% vs. 3%; P < 0.001). In inflammatory bowel disease, arthralgia relief was reported by 32 patients (71%): complete relief by eight patients (18%) and partial relief by 24 (53%). Thirteen patients (29%) reported no benefit. A comparable percentage of inflammatory bowel disease patients and controls reported arthralgia relief (71% vs. 70%). CONCLUSIONS: Rofecoxib appears to control arthralgia in almost two-thirds of inflammatory bowel disease patients. Side-effects requiring drug discontinuation are observed, however, in almost one-quarter of patients. |
| | |
Authors:
|
L Biancone; C Tosti; A Geremia; D Fina; C Petruzziello; S Emerenziani; F Pallone |
Related Documents
:
|
19070446 - The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled m... 18072056 - Characterization of yellow plaques found in the small bowel during double-balloon enter... 22482896 - Angle-closure glaucoma secondary to topiramate use. 17828776 - Pilot study on the effect of reducing dietary fodmap intake on bowel function in patien... 16354276 - An overview of regular dialysis treatment in japan as of 31 december 2003. 1464866 - Kates forefoot arthroplasty in rheumatoid arthritis. a 5-year followup study. |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: Alimentary pharmacology & therapeutics Volume: 19 ISSN: 0269-2813 ISO Abbreviation: Aliment. Pharmacol. Ther. Publication Date: 2004 Apr |
Date Detail:
|
Created Date: 2004-03-26 Completed Date: 2004-07-20 Revised Date: 2005-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8707234 Medline TA: Aliment Pharmacol Ther Country: England |
Other Details:
|
Languages: eng Pagination: 755-64 Citation Subset: IM |
Affiliation:
|
Cattedra di Gastroenterologia, Dipartimento di Medicina Interna, Center of Excellence for the Study of the Genomic Risk of Complex Multifactorial Diseases, Università degli Studi di Roma Tor Vergata, Rome, Italy. biancone@med.uniroma2.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Anti-Inflammatory Agents, Non-Steroidal / adverse effects, therapeutic use* Arthralgia / drug therapy* Colitis, Ulcerative / drug therapy* Crohn Disease / drug therapy* Cyclooxygenase Inhibitors / adverse effects, therapeutic use* Female Humans Lactones / adverse effects, therapeutic use* Male Middle Aged Prospective Studies Recurrence Sulfones Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Cyclooxygenase Inhibitors; 0/Lactones; 0/Sulfones; 0/rofecoxib |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a c...
Next Document: Diverticular disease of the colon: ethnic differences in frequency.